Phil Inc scores $25 mln Series B
San Francisco-based Phil Inc, a technology platform for distributing and managing specialty prescription drugs, has raised $25 million in Series B funding. GreatPoint Ventures led the round with participation from Tarsadia Investments, Crosslink Capital and Uncork Capital.
15 May 2019•1 min read
